Uveal melanoma: ESMO 2025 updates in 2 minutes

New data from ESMO 2025 highlight striking results for AnzuCell therapy and novel combination strategies in uveal melanoma. Associate Professor Marco Donia, MD, PhD, University of Copenhagen & Clinician-Scientist at Herlev Hospital, Denmark, presents the most promising studies and future perspectives for systemic treatment.